Molecular determinants of disease severity in urinary tract

Nonantibiotic prevention and management of recurrent urinary tract

Timing is everything: impact of development, ageing and circadian

Pathogens, Free Full-Text

Frontiers Programmed Cell Death-Ligand-1 expression in Bladder

Cells, Free Full-Text

COVID-19 and Kidney Disease: Molecular Determinants and Clinical

Molecular determinants of disease severity in urinary tract

Pathogens, Free Full-Text

Neutrophil recruitment to the urinary tract following E. coli

Molecular determinants of disease severity in urinary tract

Diagnostics, Free Full-Text

Infection history alters acute bladder inflammation kinetics

Nuclear IRF3 translocation after stimulation with P-fimbriated E

Frontiers Deciphering the virulence factors, regulation, and